Towards Healthcare Research & Consulting

U.S. Central Lab Companies Strategic Expansion

Date : 02 June 2026

Top Companies in the U.S. Central Lab Market & Their Offerings

U.S. Central Lab Market Companies are LabCorp, Quest Diagnostics, IQVIA, Thermo Fisher Scientific, Eurofins Scientific , Medpace

Companies Headquarters Offerings
Labcorp Burlington, North Carolina, USA Central laboratory services, clinical trial testing, biomarker analysis, genetic testing, drug development support, and comprehensive diagnostic solutions for pharmaceutical and biotech studies.
Quest Diagnostics New Jersey, USA Clinical trial laboratory services, routine and advanced diagnostic testing, molecular and genomic testing, and data-driven clinical research support.
IQVIA North Carolina, USA Central lab services, clinical trial management, data analytics, real-world evidence generation, and integrated clinical research solutions.
Thermo Fisher Scientific Massachusetts, USA Analytical testing services, biospecimen management, biomarker discovery support, laboratory instrumentation, and clinical trial laboratory solutions.
Eurofins Scientific Luxembourg Central laboratory testing, bioanalytical services, genomic and molecular testing, sample management, and clinical research support services.
Medpace Cincinnati, Ohio, USA Full-service clinical research organization with central lab services including clinical trial testing, bioanalysis, data management, and regulatory support.

What are the Recent Developments in the U.S. Central Lab Market? 

  • In April 2025, Labcorp launched its new pTau-217/Beta Amyloid 42 Ratio blood-based biomarker test to support faster Alzheimer’s disease diagnosis and strengthen precision medicine testing capabilities.
  • In January 2025, Quest Diagnostics completed the acquisition of University Hospitals’ outreach laboratory services business in Ohio to expand its centralized testing network and improve

Market Growth

The U.S. central lab market size was estimated at USD 2.37 billion in 2025 and is predicted to increase from USD 2.58 billion in 2026 to approximately USD 5.19 billion by 2035, expanding at a CAGR of 8.08% from 2026 to 2035.

U.S. Central Lab Market Size is USD 2.58 Billion in 2026.